Real-time enrollment status for this non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:45 PM UTC
| NCT Number | NCT05826535 |
| Recruiting Status | Recruiting |
| Condition | Non-Hodgkin Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 270 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Lyell Immunopharma, Inc. |
| Last Updated on CT.gov | August 25, 2026 (Aug 25, 2026) |
As of October 15, 2026: Clinical trial NCT05826535 is currently recruiting participants. This phase1 study for non-hodgkin lymphoma is actively seeking new participants at 32 locations across the United States. The study is sponsored by Lyell Immunopharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05826535 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05826535 was last updated Aug 25, 2026 (August 25, 2026). HelloStudys verifies this status automatically.